Latest stories on ARCT
Arcturus Therapeutics Holdings Inc. (ARCT) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
Seeking Alpha56 · neutralgeneral
Arcturus Therapeutics price target raised to $41 from $20 at Roth Capital
The Fly63 · neutralanalyst
Why is Arcturus Therapeutics stock surging today?
Investing.com Markets50 · neutralgeneral
Arcturus Therapeutics to Participate in Upcoming Investor Conferences
StockTitan56 · neutralgeneral
Arcturus, Moderna fall after BioNTech's cancer vaccine setback
Seeking Alpha34 · bearishgeneral
Arcturus Therapeutics Highlights ARCT-810 Progress at Metabolic Symposium
TipRanks63 · neutralproduct/pr
Arcturus Therapeutics Holdings Inc. (ARCT) files 8-K
SEC 8-K50 · neutralgeneral
ARCT Surges Over 60% Toward Best Week In Year As Moderna Cancer Win Lifts Sector — Retail Says Arcturus Getting ‘Harder To Dismiss’
Stocktwits News73 · bullishproduct/pr
SLS, IBRX Stocks In Focus: Analyst Says Moderna-Merck Cancer Vaccine Success ‘Bodes Well’ For Oncology
Stocktwits News73 · bullishproduct/pr
ARCT Defies mRNA Selloff And Extends Rally As Moderna, BioNTech Shares Pull Back
Stocktwits News63 · neutralproduct/pr
Moderna Is Now S&P 500’s No. 2 Stock This Year — Wall Street, Jim Cramer And Elon Musk Cheer Cancer Vaccine Breakthrough
Stocktwits News73 · bullishproduct/pr
Arcturus Therapeutics Earnings Call Balances Progress, Pressure
TipRanks53 · neutralearnings
Arcturus (ARCT) Q2 2026 Earnings Call Transcript
The Motley Fool56 · neutralearnings
Arcturus Strengthens Pipeline as Key Phase 2 Milestones Approach and KOSTAIVE® Rights Return
August 7, 2026
MarketChameleon67 · bullishproduct/pr
Arcturus targets Q4 2026 Phase III decision for ARCT-032 as it regains global KOSTAIVE rights
Seeking Alpha63 · neutralproduct/pr
Arcturus Therapeutics Holdings Inc. (ARCT) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Arcturus Therapeutics Price Target Lowered To 20 From 21 At Canaccord
The Fly34 · bearishanalyst
Arcturus Therapeutics Q2 Earnings Call Highlights
Yahoo Top63 · neutralearnings
Arcturus Therapeutics Reports Q2 Eps 84c Consensus 1 03
The Fly46 · neutralearnings
Arcturus Therapeutics Holdings Inc. (ARCT) files 8-K
SEC 8-K50 · neutralgeneral
Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress
StockTitan59 · neutralproduct/pr
Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026
StockTitan50 · neutralgeneral
Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
StockTitan55 · neutralgeneral
Arcturus: Now That It's Come This Low, It's Time To Buy And Hold
Seeking Alpha58 · neutralgeneral